Detalhe da pesquisa
1.
Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19.
Int J Infect Dis;
122: 585-592, 2022 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35788416
2.
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naïve adults ≥50 years of age.
Vaccine;
36(45): 6875-6882, 2018 10 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29559167
3.
Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults.
Vaccine;
33(24): 2793-9, 2015 Jun 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25913828